Comparative effectiveness of two- and three-dose schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study
暂无分享，去创建一个
A. Mehrkar | B. Goldacre | D. Nitsch | W. Hulme | E. J. Carr | The OpenSAFELY Collaborative | V. Mahalingasivam | F. Loud | E. Parker | R. Steenkamp | J. Tazare | E. Horne | S. Lyon | S. Santhakumaran | J. Sterne | B. Zheng | L. Tomlinson | B. Mackenna | M. Scanlon | T. Collaborative